FAQs

If you participate in SKYGLO, you’ll be contributing to research which may help others with LBCL in the future. In addition, you may receive regular health monitoring and access to an approved LBCL treatment.

We can never be sure of how the investigational drug will affect you. So, if you take part, your health may improve, stay the same, or even get worse. You may also experience unwanted effects from the study drugs.

In order to participate in this clinical study, it is mandatory that you use a reliable birth control method (if applicable). If you’re currently pregnant, breastfeeding, or thinking of getting pregnant, you will not be able to join this study.

No. Taking part in a clinical research study is completely voluntary, and you can leave at any time. If you do decide to leave the study for any reason, it will help the study team if you are able to attend any follow-up visits they may invite you to, or agree to talk to them on the phone so that they can see how you are after you leave the study. This may help to know more about the investigational study drug, and could help other people in the future.

If you decide that participation is right for you, you may be compensated for each study visit that you attend. This will depend on the local regulations of your study clinic. You may also be reimbursed for your travel and parking costs.

Your personal data and medical samples will be labeled with a participant identification (ID) number that is unique to you and not related to or derived from information that identifies you (such as your name or any other personally identifying information). If you’re interested and would like more information on how your data will be protected, please ask the study doctor.